570 China Traditional Chinese Medicine Holdings Co. Ltd.
China Traditional Chinese Medicine Holdings Co. (570) news
China Traditional Chinese Medicine Holdings Co. Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 570, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Latest China Traditional Chinese Medicine Holdings Co. news
We have not published a story on China Traditional Chinese Medicine Holdings Co. yet. When there is news, it will appear here.
Questions about China Traditional Chinese Medicine Holdings Co.
What is the ticker symbol of China Traditional Chinese Medicine Holdings Co.?
China Traditional Chinese Medicine Holdings Co. Ltd. trades under the ticker 570 on HKEX.
Where is China Traditional Chinese Medicine Holdings Co. listed?
China Traditional Chinese Medicine Holdings Co. Ltd. is listed on HKEX.
Which country or territory is China Traditional Chinese Medicine Holdings Co. listed under?
Our directory records China Traditional Chinese Medicine Holdings Co. Ltd. under Hong Kong.
What does China Traditional Chinese Medicine Holdings Co. do?
Our directory classifies China Traditional Chinese Medicine Holdings Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of China Traditional Chinese Medicine Holdings Co.?
The ISIN recorded for China Traditional Chinese Medicine Holdings Co. Ltd. is HK0000056256.
Does aibio.space cover China Traditional Chinese Medicine Holdings Co.?
aibio.space lists China Traditional Chinese Medicine Holdings Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear.
Which companies are similar to China Traditional Chinese Medicine Holdings Co.?
Companies in our directory listed in the same country and business area as China Traditional Chinese Medicine Holdings Co.: Sanai Health Industry Group Company, Pak Fah Yeow International, Grand Pharmaceutical Group, Dawnrays Pharmaceutical Holdings, Regencell Bioscience Holdings, Extrawell Pharmaceutical Holdings.
Investor discussion: China Traditional Chinese Medicine Holdings Co.
Rules
- Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
- Say whether you hold the stock. Every post states long, short or no position.
- No paid or sponsored posts. Do not post for anyone who pays or rewards you.
- No buy or sell calls and no price targets.
- No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
- No personal details and no spam. No links at all for your first 7 days as a member.
Press releases
- HKEXnews
Letter to Non-registered Shareholders and Reply Form - Notice of Publication of Interim Report 2026
- HKEXnews
Letter to Registered Shareholders and Reply Form - Notice of Publication of Interim Report 2026
- HKEXnews
- HKEXnews
- HKEXnews
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026
- HKEXnews
- HKEXnews
CHANGE OF EXECUTIVE DIRECTOR, CHAIRMAN AND AUTHORISED REPRESENTATIVE
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
- HKEXnews
Letter to Non-registered Shareholders and Reply Form - Notice of Publication of Annual Report 2025
- HKEXnews
Letter to Registered Shareholders and Reply Form - Notice of Publication of Annual Report 2025
- HKEXnews
ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
- HKEXnews
POLL RESULTS OF EXTRAORDINARY GENERAL MEETING HELD ON 2 FEBRUARY 2026
- HKEXnews
- HKEXnews
- HKEXnews
Stock chart
Listing details
- Company
- China Traditional Chinese Medicine Holdings Co. Ltd.
- Ticker
- 570
- Listing
- HKEX
- Country or territory
- Hong Kong
- Business scope
- Pharmaceuticals: Major
- ISIN
- HK0000056256
- Last quote in directory
- 2026-10-22
- Directory source
- Listing page
Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio